PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds that proven medications for alcohol use disorder are rarely given to adolescents and young adults on public insurance

2023-06-14
(Press-News.org) BOSTON – Heavy drinking commonly begins in adolescence and is a known risk factor for the development of alcohol use disorder (AUD). Data from adult clinical trials suggest offering evidence-based medications for AUD to younger adults could promote their engagement in treatment and improve clinical outcomes.

But are those medications being used when and where they are needed? In a review of claims data for youths insured by Medicated in 15 U.S. states, a team of researchers found that most youths with a diagnosis of AUD do not receive medications as part of their therapy, despite recommendations from national organizations to consider their use.

The team, which was led by Scott Hadland, MD, MPH, chief of Adolescent and Young Adult Medicine at Mass General for Children, recently published their findings in the Journal of Adolescent Health.

FDA-approved medications for AUD include naltrexone, acamprosate and disulfiram—all of which have been proven effective in helping to maintain abstinence among adults with AUD. While these medications are currently approved for adults 18 and over, the Substance Abuse and Mental Health Services Administration recommends considering them for adolescents under 18 as well.

To study if and how these medications were being used, the team looked at Medicaid claims data from 4.7 M youths aged 13-22 in 15 states. From that group, they identified approximately 14,000 youths who were diagnosed with an AUD during the study period (2014 to 2019) and met the criteria for inclusion.

Of that group, 10,851 or 76.4% received treatment for AUD within 30 days of diagnosis. The vast majority—nearly 98% percent—received behavioral health services as treatment. Only 2% of youths received AUD medication on its own or in combination with behavioral health treatment.

The findings point to an opportunity to improve medication access to this vulnerable populations, the researchers say.

“Treating addiction as early as possible is critical to preventing lifetime problems, and the failure to offer medications to young people with an alcohol problem may represent a missed opportunity,” says Hadland, the senior author of the study. “Without medications, we know that psychosocial interventions may have limited efficacy for some patients, while pharmacotherapy can clearly reduce drinking in adults with alcohol addiction.”

“While these three medications are only FDA-approved for people 18 years and over, we know they effectively reduce cravings for alcohol and are associated with reductions in heavy drinking episodes in this older population,” Hadland points out. “Clinical trials are urgently needed to assess the effectiveness of these AUD medicines in adolescents under 18, but even the young adults aged 18 to 22 in our study rarely received medications despite their important role in treatment.”

Hadland, an international leader in educating other pediatricians and general practitioners on addressing mental health and substance use in youth, believes that policymakers and clinicians have an important role to play in increasing public access to pharmacology for alcohol addiction.

Potential strategies for increasing medication use, particularly for young adults for whom medications are recommended, include continuing education for practicing clinicians and stronger training on AUD screening, diagnosis and treatment in medical school and residency, the research team writes.

“Medications for alcohol use disorder are underused in all ages,” emphasizes Hadland, “and stronger addiction training for clinicians is needed, along with better reimbursement for drug and alcohol treatment to incentivize clinicians to provide evidence-based care.”

Hadland is an associate professor of Pediatrics at Harvard Medical School. Lead author Joel Earlywine is a health policy analyst at Mathematica.

The study was funded by the National Institute on Drug Abuse (NIDA).

 

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2021, Mass General was named #5 in the U.S. News & World Report list of "America’s Best Hospitals." MGH is a founding member of the Mass General Brigham healthcare system.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Phosphate, a key building block of life, found on Saturn’s moon Enceladus

Phosphate, a key building block of life, found on Saturn’s moon Enceladus
2023-06-14
An international team including a University of Washington scientist has found that the water on one of Saturn’s moons harbors phosphates, a key building block of life. The team led by the Freie Universität Berlin used data from NASA’s Cassini space mission to detect phosphates in particles ejected from the ice-covered global ocean of Saturn’s moon Enceladus. Phosphorus, in the form of phosphates, is vital for all life on Earth. It forms the backbone of DNA and is part of cell membranes and bones. The new study, published June 14 in ...

Conflict in marriage less harmful for kids when dad keeps it constructive

Conflict in marriage less harmful for kids when dad keeps it constructive
2023-06-14
URBANA, Ill. — Conflict is unavoidable in all marriages. When it erupts in families with children, stressed or angry parents may take their pain out on the kids, projecting their anger or withdrawing emotionally or physically. In the worst cases, children’s socioemotional development can suffer. But the way parents, especially fathers, deal with marital conflict can make a difference to kids, according to a new study from researchers at the University of Illinois Urbana-Champaign. “In the past, marital conflict ...

Ten ways to increase Latino participation in Alzheimer’s research from leaders in health equity science

2023-06-14
CHICAGO, June 14, 2023 -- Leaders in health equity have issued an urgent call to address the underrepresentation of U.S. Latinos in Alzheimer's and dementia clinical trials. Their recommendations are outlined in an article published online today by Alzheimer's & Dementia: Translational Research & Clinical Interventions.   “A call to address structural barriers to the representation of Hispanics/Latinos in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective,” was led by first author María P. Aranda, ...

National economies recover faster when countries are powered by renewable energy – new research

2023-06-14
National economies recover significantly faster from shocks when countries are powered by renewable energy sources, according to new research that has profound implications for global energy policy. Researchers from Trinity College Dublin looked for patterns in data from 133 systemic economic crises that affected 98 countries over a 40-year span. And while their analyses show that countries relying on a broader range of energy sources experience longer recovery times, the best predictor of economic recovery was the extent to which a country relied on renewable energy. Underlining the significance of the finding is the fact that while data ...

A machine learning approach to freshwater analysis

A machine learning approach to freshwater analysis
2023-06-14
From protecting biodiversity to ensuring the safety of drinking water, the biochemical makeup of rivers and streams around the United States is critical for human and environmental welfare. Studies have found that human activity and urbanization are driving salinization (increased salt content) of freshwater sources across the country. In excess, salinity can make water undrinkable, increase the cost of treating water, and harm freshwater fish and wildlife. Along with the rise in salinity has also been an increase in alkalinity over time, and past research suggests that salinization may enhance alkalinization. But unlike excess salinity, ...

Inflammatory bowel disease linked to increased risk of stroke

2023-06-14
MINNEAPOLIS – People with inflammatory bowel disease (IBD) are more likely to have a stroke than people without the disease, according to a study published in the June 14, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that IBD causes stroke; it only shows an association. Inflammatory bowel disease causes chronic inflammation of the intestines. It includes Crohn’s disease, ulcerative colitis and unclassified inflammatory bowel disease. The study found that people with IBD were 13% more likely to have a stroke up to ...

UCF researcher’s innovative approach could redefine allergy treatment

2023-06-14
For years, research and therapies for allergic asthma have been focused largely on targeting the inflammatory cytokines in the body that react to allergens and cause overproduction of mucus, wheezing and difficulty breathing. Commonly prescribed drugs like Omalizumab, Dupilumab, Mepolizumab and Reslizumab lower or block the various cytokines and antibodies responsible for the asthmatic response, but they work after a patient’s airway inflammation is well underway. Dr. Tigno-Aranjuez wanted to ...

ACSL4: Biomarker, mediator and target in quadruple negative breast cancer

ACSL4: Biomarker, mediator and target in quadruple negative breast cancer
2023-06-14
“ACSL4 has been demonstrated to play a pivotal role in both normal physiology as well as in a variety of disease states, including breast and other cancers.” BUFFALO, NY- June 14, 2023 – A new review paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, “ACSL4: biomarker, mediator and target in quadruple negative breast cancer.” Breast cancer is a heterogeneous disease for which effective treatment depends on correct categorization of its molecular subtype. ...

UTIA researchers find high risk to amphibians if fungal pathogen invades North America

UTIA researchers find high risk to amphibians if fungal pathogen invades North America
2023-06-14
New research indicates the fungal pathogen Batrachochytrium salamandrivorans (Bsal) could be devastating to amphibian biodiversity if introduced to North America. Nature Communications published the findings June 5 from a group of researchers at the University of Tennessee Institute of Agriculture, the University of Massachusetts-Boston and Washington State University. “We could see over 80 species of salamanders in the United States and 140 species in North America experience population declines if Bsal is introduced,” said Matt Gray, the lead author and professor of ...

New images capture unseen details of the synapse

New images capture unseen details of the synapse
2023-06-14
Scientists have created one of the most detailed 3D images of the synapse, the important juncture where neurons communicate with each other through an exchange of chemical signals.  These nanometer scale models will help scientists better understand and study neurodegenerative diseases such as Huntington’s disease and schizophrenia.  The new study appears in the journal PNAS and was authored by a team led by Steve Goldman, MD, PhD, co-director of the Center for Translational Neuromedicine at the University of Rochester and the University of Copenhagen. The findings represent a significant technical achievement ...

LAST 30 PRESS RELEASES:

US vacation renters waste $2 billion worth of food annually

Automatized vocabulary knowledge in predicting speech fluency

Uncovering the relationship between oral function and lifestyle-related diseases

Drone herbicide applications prove effective for common reed control

New report shows China dominates in AI research – and is western world’s leading collaborator on AI

Hot weather causes children to sweat at the same rate as adults, study shows

New CZI AI model could help scientists pinpoint signs of cancer cells

Sugar-coated ‘sticky’ stem cells could unlock surgery-free liver treatments

Children’s social media activity highlights emotional stress of living with long-term health issues

New tool maps hidden roles and risks in ecosystems

New breakthrough method to protect quantum spins from noise

Chemicals from turmeric and rhubarb could help fight antibiotic-resistant bacteria lurking in wastewater

Instant cancer diagnosis with light and AI!

New electroenzymatic strategy enables non-natural oxidation reactions

Tunable laser light

Scientists uncover magnetic-field control of ultrafast spin dynamics in 2D ferromagnets

New AI-powered model accurately predicts lung motion with minimal radiation

AI language models show promise in predicting liver cancer treatment outcomes

Tracking insect and bug health in a heartbeat from a digital camera

'Talking fish' not heard by conservation policies, SFU study warns

Thirty years of research shows increased resistance in fungi

Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship

Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech

Ancient river systems reveal Mars was wetter than we thought

Online toolkit to help parents of autistic children improve dental health

The psychological and neurological parallels between sports fandom and religious devotion

Agricultural liming in the US is a large CO2 sink, say researchers

Seaside more likely to make us nostalgic than green places, study finds

Psilocybin delays aging, extends lifespan, Emory study suggests

Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform

[Press-News.org] Study finds that proven medications for alcohol use disorder are rarely given to adolescents and young adults on public insurance